𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine

✍ Scribed by T. A. Lasher; J. C. Fleishaker; R. C. Steenwyk; E. J. Antal


Publisher
Springer
Year
1991
Tongue
English
Weight
745 KB
Volume
104
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetics and pharmacodynamics of
✍ R. B. Smith; P. D. Kroboth; J. T. Vanderlugt; J. P. Phillips; R. P. Juhl πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 511 KB

Six fasting male subjects (20-32 years of age) received an oral tablet and an IV 1.0-mg dose of alprazolam in a crossover-design study. Alprazolam plasma concentration in multiple samples during 36 h after dosing was determined by electron-capture gas-liquid chromatography. Psychomotor performance t

Pharmacokinetic and pharmacodynamic eval
✍ David Stepensky; Gershon Golomb; Amnon Hoffman πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 148 KB

We studied the differences in pharmacokinetics and pharmacodynamics of the same dose of alendronate administered subcutaneously as intermittent bolus injection or continuous infusion in rats. Two rat models of bone disease were applied. Bone cancer was produced by intratibial inoculation of Walker c

Pharmacokinetic and pharmacodynamic eval
✍ Oliver Ghobrial; Hartmut Derendorf; Jeffrey D. Hillman πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 166 KB

Presented are the pharmacokinetics (PK), exposure-response relationship, and the PK/pharmacodynamic (PD) index predictive of maximum therapeutic efficacy for the lantibiotic MU1140. MU1140, at a dose of 12.5 or 25 mg/kg, was administered intravenously, to characterize its PK parameters in rat. The r